Inas K. Sharquie
Baghdad, BG, Iraq
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Machine Learning-Based Analysis of Serum Interleukin-39 and Interleukin-40 Levels for Differentiating Rheumatoid Arthritis and Systemic Lupus Erythematosus.
Journal: Medeniyet medical journal
Published: January 02, 2026
Serum Interleukin-40 and Soluble CD40 Ligand as Complementary Biomarkers for Disease Activity in Multiple Sclerosis Patients.
Journal: Medeniyet medical journal
Published: January 02, 2026
IL-41: A novel serum marker correlates with disease activity in patients with ankylosing spondylitis.
Journal: The Medical journal of Malaysia
Published: November 30, 2024
Alarming update on incidence of Crimean-Congo hemorrhagic fever in Iraq in 2023.
Journal: IJID regions
Published: September 29, 2023
Serum interleukin 40: an innovative diagnostic biomarker for patients with systemic lupus erythematosus.
Journal: The Medical journal of Malaysia
Published: September 29, 2023
Biomarker significance of interleukins, IL-37 and IL-38 in patients with juvenile idiopathic arthritis.
Journal: The Medical journal of Malaysia
Published: July 28, 2022
Evaluation of interleukin-38 levels in serum of patients with coronavirus disease 2019.
Journal: Journal of medical virology
Published: January 25, 2022
Serum Glial Fibrillary Acidic Protein: A Surrogate Marker of the Activity of Multiple Sclerosis.
Journal: Medeniyet medical journal
Published: August 01, 2020
Is hyaluronic acid filler still a potential risk factor for an autoimmune reaction?
Journal: The Medical journal of Malaysia
Published: July 30, 2020
Serum Glutamate Is a Predictor for the Diagnosis of Multiple Sclerosis.
Journal: TheScientificWorldJournal
Published: March 06, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026